Epidemiology of glomerulonephritis in Northern Germany

Braun, Norbert; Schweisfurth, Anna; Lohöfener, Christine; Lange, Catalina; Gründemann, Christian; Kundt, Günther; Gröne, Hermann Josef

doi:10.1007/s11255-011-9955-4

Cited by 43 publications

(24 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…IgAN incidence ranges from 0.20 to 2.80 php/yr globally, with this study showing that the Queensland incidence of 1.41 php/yr (range 1.19 to 1.82 php/yr) is a near median finding . IgAN has also been the leading primary GN across centres in Asia, Europe and North America . The lowest incidence of IgAN has been reported in the Middle East and South America, averaging fewer than 0.30 cases php/yr.…”

Section: Discussionmentioning

confidence: 56%

Epidemiology of biopsy‐proven glomerulonephritis in Queensland adults

et al. 2015

View full text Add to dashboard Cite

IgA nephropathy is the predominant primary GN in Queensland, and nephrotic syndrome the most common indication for a renal biopsy. While crescentic GN incidence has significantly increased with time, focal segmental glomerulosclerosis incidence has not shown any trend. Incidence of GN overall appears to increase with age. The annual rate of biopsy in this study appears lower than previously published in an Australian population.

show abstract

Section: Discussionmentioning

confidence: 56%

Epidemiology of biopsy‐proven glomerulonephritis in Queensland adults

et al. 2015

View full text Add to dashboard Cite

show abstract

“…In 9 national renal biopsy registries (Scotland, Italy, Spain, Czech Republic, Japan, Brazil, Bahrain, Uruguay, Denmark) [17][18][19][20][21][22][23][24][25][26][27][28], the median total number of biopsies performed was 1,818, ranging from 498 [20] to 14,607 [24] . In data from 6 macro-regional databases (France, Finland, Romania, Australia, North Germany, West Saudi Arabia) [29][30][31][32][33][34][35] and 12 single-center reports [36][37][38][39][40][41][42][43][44][45][46][47] , the overall number of biopsies ranged from 251 [29] to 3,310 [34] .…”

Section: Renal Biopsy: a Global Epidemiology Overviewmentioning

confidence: 99%

Renal Biopsy in 2015 - From Epidemiology to Evidence-Based Indications

Fiorentino

Bolignano²,

Tesař³

et al. 2016

Am J Nephrol

131

102

View full text Add to dashboard Cite

Background: Although the number of patients reaching end-stage kidney disease without a biopsy-proven diagnosis is increasing, the utility of renal biopsy is still an object of debate. We analyzed epidemiological data and the main indications for renal biopsy with a systematic, evidence-based review at current literature. Summary: There is a high discrepancy observed in biopsy rates and in the epidemiology of glomerular diseases worldwide, related to the different time frame of the analyzed reports, lack of data collection, the different reference source population and the heterogeneity of indications. The evidence-based analysis of indications showed that renal biopsy should be crucial in adults with nephrotic syndrome or urinary abnormalities as coexistent hematuria and proteinuria and in corticosteroid resistant-children with severe proteinuria. The knowledge of renal histology can change the clinical management in patients with acute kidney injury significantly, after the exclusion of pre-renal or obstructive causes of kidney damage. Scarce evidence indicates that renal biopsy can be useful in patients with advanced chronic kidney disease and its use should always be considered after weighing the benefits and potential risks. Renal biopsy should be crucial in patients with renal involvement due to systemic disease. In patients with diabetes with atypical features, renal biopsy may be fundamental to diagnose an unexpected parenchymal disease mislabeled as diabetic nephropathy. Finally, in elderly patients, the indications and the risks are not different from those in the general population. Key Message: Renal biopsy still remains a concrete approach for managing a substantial percentage of renal diseases.

show abstract

“…In addition, data from local or limited national registries of renal biopsy have been reported from South Korea [10,11], Bahrain [12,13], Brazil [14], Romania [15], China [16], Finland [17], Serbia [18], Pakistan [19] and Belgium [20]. Finally, there are also reports that include epidemiological data only on glomerular diseases from Australia [21], Macedonia [22], France [23], USA [24], Iran [25], Germany [26], Lebanon [27], Peru [28] and Poland [29]. In this study we describe the frequency and clinicopathological correlations of biopsy-proven native renal diseases in Croatian adults observed over past 15 years.…”

Section: Introductionmentioning

confidence: 99%

Epidemiologic data of adult native biopsy-proven renal diseases in Croatia

et al. 2013

View full text Add to dashboard Cite

PURPOSE: There is a paucity of epidemiological data on biopsy-proven renal disease in Croatia. The purpose of this report is a review of clinical and histological data, over a period of 15 years, from the single biggest adult native renal biopsy centre in Croatia.METHODS: This report includes data from 922 adult native renal biopsies in patients referred from the whole country and performed in our centre from 1996 till February 2012. Data on age, gender, serum creatinine, urine sediment, 24-hour proteinuria, clinical syndrome and histological diagnosis were collected and analyzed retrospectively. In all patients light, immunofluorescence and electron microscopic analysis was performed.RESULTS: The median age of the patients was 48 years (interquartile range 36-59 years), and the majority of patients were men (57.8%). The most common indication for renal biopsy was nephrotic syndrome (40.3%) followed by asymptomatic urinary abnormalities (31.7%). The most common biopsy-proven renal disease in total was IgA glomerulonephritis (19.3%), followed by FSGS (15.8%) and membranous glomerulonephritis (9.2%). In men similar results were found, while in women the most common were hereditary nephritis (13.4%), FSGS (12.9%) and connective tissue disease-related glomerular disorders (11.6%).CONCLUSION: The presented data are an important contribution to the better understanding of the epidemiology of biopsy-proven renal disease in Croatia and Europe throughout comparison with other registry data. This data should be the basis for the formation of Croatian Registry of Renal Biopsies.

show abstract

Epidemiology of glomerulonephritis in Northern Germany

Cited by 43 publications

References 18 publications

Epidemiology of biopsy‐proven glomerulonephritis in Queensland adults

Epidemiology of biopsy‐proven glomerulonephritis in Queensland adults

Renal Biopsy in 2015 - From Epidemiology to Evidence-Based Indications

Epidemiologic data of adult native biopsy-proven renal diseases in Croatia

Contact Info

Product

Resources

About